Bloodstream yeast infections: a 15-month survey

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Epidemiology and Infection

• Publication date

  2009-01-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S0950268808001763PMID 19134233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Yeasts Characteristics and Identification, 3rd edition

  2009cited by this paper
• Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species

  2007cited by this paper
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

  2007cited by this paper
• Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

  2006cited by this paper
• Candidaemia in Europe: epidemiology and resistance.

  2006cited by this paper
• Actividad in vitro del voriconazol, fluconazol, itraconazol y anfotericina B contra levaduras no Candida albicans

  2005cited by this paper
• In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.

  2005cited by this paper
• A one-year survey of candidemia in Belgium in 2002

  2004cited by this paper
• Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

  2002cited by this paper
• Microsatellite Typing as a New Tool for Identification of Saccharomyces cerevisiae Strains

  2001cited by this paper
• Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation

  1995cited by this paper
• Yeasts: Characteristics and Identification

  1983cited by this paper

• Beyond Candida: Epidemiological Insights into Rare Yeast Fungaemia in Greece from a 15-Year Hospital-Based Study and Literature Review

  2026cites this paper
• Saccharomyces cerevisiae fungemias: how heterogenous is their management?

  2024cites this paper
• Epidemiology of Saccharomyces fungemia: a systematic review.

  2023cites this paper
• Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries

  2022cites this paper
• NOTE show low levels of traversal across Saccharomyces cerevisiae the human blood brain barrier in vitro

  2019cites this paper
• Population genomics reveals evolution and variation of Saccharomyces cerevisiae in the human and insects gut

  2018cites this paper
• Saccharomyces cerevisiae show low levels of traversal across human endothelial barrier in vitro

  2017cites this paper
• NOTE show low levels of traversal across Saccharomyces cerevisiae the human blood brain barrier in vitro

  2017cites this paper
• Epidemiology of Bloodstream Infections

  2017cites this paper
• A dedicated fungal culture medium is useful in the diagnosis of fungemia: a retrospective cross-sectional study

  2016cites this paper
• fungistatic effect of weak organic acids 2

  2015cites this paper
• MIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids

  2015cites this paper
• Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine model.

  2015cites this paper
• Trends in antifungal susceptibility of Candida species--one year observation.

  2014influential citation
• Candidaemia in polish hospitals – a multicentre survey

  2013cites this paper
• FLO11 expression in clinical and non-clinical Saccharomyces cerevisiae strains and its association with virulence

  2013cites this paper
• Clinical Saccharomyces cerevisiae isolates cannot cross the epithelial barrier in vitro.

  2012cites this paper
• Murine Model of Dextran Sulfate Sodium-induced Colitis Reveals Candida glabrata Virulence and Contribution of β-Mannosyltransferases*

  2012cites this paper
• Caspofungin: when and how? The microbiologist’s view

  2012cites this paper
• Evaluation of fluorescence in situ hybridisation (FISH) for the identification of Candida albicans in comparison with three phenotypic methods

  2012cites this paper
• Ten-Year Study of Species Distribution and Antifungal Susceptibilities of Candida Bloodstream Isolates at a Brazilian Tertiary Hospital

  2012cites this paper
• Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains

  2012cites this paper
• Impact of yeast-bacteria coinfection on the detection of Candida sp. in an automated blood culture system.

  2012cites this paper
• Estudo retrospectivo de dez anos de candidemia em hospital terciário de Campo Grande-MS, Brasil

  2011cites this paper
• Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.

  2011cites this paper
• In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits.

  2011cites this paper
• Molecular Identification of Veterinary Yeast Isolates by Use of Sequence-Based Analysis of the D1/D2 Region of the Large Ribosomal Subunit

  2010cites this paper
• THE EFFECTS OF THE INTESTINAL ENVIRONMENT ON SALMONELLA PATHOGENESIS AND MOLECULAR IDENTIFICATION OF MICROBES IN THE CLINICAL LABORATORY

  2010cites this paper
• The echinocandins: three useful choices or three too many?

  2010cites this paper
• Candida Infections and Modelling Disease

  2010cites this paper